Hepatobiliary & Pancreatic Diseases International

Scope & Guideline

Fostering collaboration for a healthier future in gastroenterology.

Introduction

Delve into the academic richness of Hepatobiliary & Pancreatic Diseases International with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1499-3872
PublisherELSEVIER
Support Open AccessNo
CountrySingapore
TypeJournal
Convergefrom 2002 to 2024
AbbreviationHEPATOB PANCREAT DIS / Hepatob. Pancreatic. Dis. Int.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Hepatobiliary & Pancreatic Diseases International' focuses on advancing knowledge in the fields of hepatology, biliary diseases, and pancreatic disorders. It aims to provide a platform for high-quality research that contributes to clinical practice and improves patient outcomes in these areas.
  1. Liver Diseases and Transplantation:
    The journal emphasizes research on various liver diseases, including hepatocellular carcinoma, liver cirrhosis, and liver transplantation techniques. It aims to improve understanding of disease mechanisms and enhance surgical and therapeutic approaches.
  2. Pancreatic Disorders:
    There is a significant focus on pancreatic diseases, particularly pancreatic cancer and pancreatitis. The journal publishes studies on diagnosis, treatment strategies, and novel surgical techniques related to these conditions.
  3. Biliary Pathology:
    Research on biliary diseases, including cholangiocarcinoma and complications from biliary interventions, is a core area. The journal explores both surgical and non-surgical management options.
  4. Innovative Surgical Techniques:
    The journal highlights advancements in surgical methods, including minimally invasive techniques and robotic surgery, aimed at improving patient outcomes in liver and pancreatic surgeries.
  5. Clinical and Translational Research:
    Emphasizing the bridge between laboratory research and clinical application, the journal encourages studies that translate scientific findings into practical treatments for liver and pancreatic diseases.
  6. Immunotherapy and Molecular Approaches:
    There is a growing interest in the role of immunotherapy and molecular biology in the treatment of hepatobiliary and pancreatic cancers, reflecting modern therapeutic strategies.
The journal has identified several emerging themes that reflect the latest advancements and interests in the fields of hepatology and pancreatic diseases. These trends are indicative of the evolving landscape of research and clinical practice.
  1. Personalized Medicine and Genomics:
    There is an increasing focus on personalized medicine approaches, including genomic profiling and tailored therapies for hepatobiliary and pancreatic cancers, reflecting the trend towards individualized patient care.
  2. Immunotherapy Advances:
    Research on immunotherapy, including checkpoint inhibitors and novel immunotherapeutic strategies, has gained significant traction, highlighting its potential in treating liver and pancreatic cancers.
  3. Artificial Intelligence and Machine Learning:
    The application of AI and machine learning for diagnostics and treatment predictions is on the rise, showcasing innovations in data-driven approaches to hepatobiliary and pancreatic diseases.
  4. Multidisciplinary Approaches to Treatment:
    Emerging themes include collaborative, multidisciplinary approaches to managing complex cases in hepatobiliary and pancreatic surgery, integrating surgical, medical, and supportive care.
  5. Microbiome and Liver Health:
    Research exploring the relationship between the gut microbiome and liver disease is gaining attention, indicating a growing interest in the microbiome's role in health and disease.
  6. Regenerative Medicine and Stem Cell Therapy:
    There is an increasing exploration of regenerative medicine and stem cell therapy as potential treatments for liver diseases, reflecting advancements in biological therapies.

Declining or Waning

While the journal continues to explore a broad range of topics, certain areas of research have shown a decline in focus over recent years. This may reflect shifts in clinical priorities or advancements in treatment methodologies that have rendered some topics less relevant.
  1. Traditional Surgical Techniques:
    There appears to be a waning emphasis on traditional open surgical techniques for hepatobiliary and pancreatic surgeries, as the field increasingly adopts minimally invasive and robotic approaches.
  2. Conventional Imaging Techniques:
    With the advent of advanced imaging modalities and radiomics, traditional imaging methods for diagnosing liver and pancreatic diseases are becoming less prominent in the journal's publications.
  3. Single-Agent Chemotherapies:
    Research focused solely on single-agent chemotherapy regimens for hepatobiliary malignancies has decreased, likely due to the shift towards combination therapies and personalized medicine.
  4. Basic Science Studies:
    There is a noticeable decline in basic science studies that do not directly translate to clinical practice, as the journal prioritizes research with immediate clinical applicability.
  5. Epidemiological Studies without Novel Insights:
    Epidemiological studies that do not provide new insights or advancements in understanding disease mechanisms or treatment are becoming less frequent.

Similar Journals

JHEP Reports

Unlocking innovations in gastroenterology and beyond.
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

JHEP Reports, published by ELSEVIER, stands at the forefront of scholarly communication in the fields of Gastroenterology, Hepatology, Immunology and Allergy, and Internal Medicine. As an Open Access journal since 2019, it provides a platform for the dissemination of high-quality research findings, making vital information readily accessible to a global audience. With a commendable impact characterized by a Q1 category ranking across four medical disciplines in 2023, JHEP Reports demonstrates its significance and influence, reflected in its impressive Scopus ranks—#11 in Gastroenterology and #14 in Internal Medicine, amongst others. This esteemed journal not only plays a critical role in advancing knowledge but also fosters collaboration among researchers, practitioners, and students keen on exploring innovations and breakthroughs in health sciences. At RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, JHEP Reports is committed to bridging the gap between research and application, ushering in a new era of informed and effective healthcare solutions.

Clinical and Molecular Hepatology

Bridging clinical practice and molecular discoveries in liver health.
Publisher: KOREAN ASSOC STUDY LIVERISSN: 2287-2728Frequency: 4 issues/year

Clinical and Molecular Hepatology, published by the Korean Association for the Study of Liver, stands at the forefront of hepatology, offering a significant platform for research and innovation in liver diseases. Established in 1995 as an open access journal, it aims to disseminate high-quality research that spans the fields of hepatology, molecular biology, and medicine. With an impressive impact factor ranking it in the Q1 category for 2023 in both Hepatology and Molecular Biology, the journal facilitates a rich exchange of knowledge among professionals, researchers, and students globally. With its dedicated coverage from 2012 to 2024 and exceptional Scopus rankings placing it within the top 10% of journals in its field, Clinical and Molecular Hepatology is an indispensable resource for advancing the understanding and treatment of liver conditions. Located in Seoul, South Korea, the journal emphasizes rigorous peer review and is committed to enhancing clinical practice and molecular research, making it an ideal venue for groundbreaking studies in liver health.

Gastroenterologia y Hepatologia

Pioneering research for better digestive disease outcomes.
Publisher: ELSEVIER ESPANA SLUISSN: 0210-5705Frequency: 10 issues/year

Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.

International Journal of Hepatology

Bridging research and clinical practice in hepatology.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

Pancreatology

Unveiling Insights into Pancreatic Diseases
Publisher: ELSEVIERISSN: 1424-3903Frequency: 6 issues/year

Pancreatology is a prestigious journal published by ELSEVIER, focusing on the multifaceted disciplines of endocrinology, diabetes, gastroenterology, and hepatology since its inception in 2001. With an impressive Q1 ranking in multiple categories, including Endocrinology and Gastroenterology, Pancreatology stands out as a critical platform for disseminating peer-reviewed research that contributes to the evolving understanding of pancreatic diseases and associated metabolic disorders. This journal has gained significant recognition in the academic community, underscored by its robust Scopus rankings, positioning it favorably among its peers. While it currently does not offer open access, Pancreatology remains committed to advancing knowledge through high-quality publications and fostering innovation in clinical practice and research. Researchers, professionals, and students are invited to engage with the cutting-edge findings within its pages, which are essential for driving progress in this essential area of medicine.

Journal of Pancreatology

Pioneering research for impactful clinical applications.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2096-5664Frequency: 4 issues/year

Journal of Pancreatology, published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Endocrinology, Diabetes and Metabolism, and Hepatology. This Open Access journal, established to disseminate cutting-edge research and advancements in pancreatic health, has witnessed a substantial rise since its inception in 2018, with converged publications spanning through 2024. Although currently ranked in the Q3 category across multiple disciplines, the journal continually seeks to elevate the discourse around pancreatic diseases and endocrine functions through high-quality articles and comprehensive studies. Researchers, professionals, and students alike will find valuable insights that can drive future investigations and clinical applications. The journal is accessible from anywhere in the world, ensuring that critical knowledge in this important field reaches a wide audience without barriers. Explore the Journal of Pancreatology to stay at the forefront of pancreatic research and contribute to meaningful developments in medical science.

HPB

Shaping the future of Gastroenterology and Hepatology.
Publisher: ELSEVIER SCI LTDISSN: 1365-182XFrequency: 12 issues/year

HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Exploring breakthroughs in gastroenterology and hepatology.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.

Hepatology Forum

Connecting professionals for a healthier tomorrow.
Publisher: KARE PUBLISSN: 1307-5888Frequency: 4 issues/year

Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.

Journal of Hepato-Biliary-Pancreatic Sciences

Innovating practices in hepatobiliary and pancreatic disorders.
Publisher: WILEYISSN: 1868-6974Frequency: 6 issues/year

The Journal of Hepato-Biliary-Pancreatic Sciences, published by WILEY, is a premier academic platform dedicated to advancing research in the domains of hepatology and surgical sciences. With an impressive impact factor and categorized as Q2 in Hepatology and Q1 in Surgery for 2023, the journal ranks #85 out of 495 in Medicine Surgery and #36 out of 70 in Medicine Hepatology, highlighting its significant contributions to the medical community. Although the journal's coverage in Scopus was discontinued from 2010 to 2021, its previous engagement with the Scopus database reinforces its relevance and quality control within the field. Researchers, clinicians, and students will find a wealth of rigorously peer-reviewed articles that address critical issues and innovative practices in the treatment of hepatobiliary and pancreatic disorders. As an essential resource for advancing knowledge and enhancing clinical practice, the Journal of Hepato-Biliary-Pancreatic Sciences aims to foster significant dialogue and collaboration among professionals dedicated to improving patient outcomes in these intertwining specialties.